Gastroenteropancreatic Neuroendocrine Tumors

Also known as: Gastroenteropancreatic neuroendocrine tumors / Gastroenteropancreatic Neuroendocrine Tumor

DrugDrug NameDrug Description
DB13985Lutetium Lu 177 dotatateA radiolabeled somatostatin analog used to treat somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors.
DrugDrug NamePhaseStatusCount
DB13925Dotatate gallium Ga-681 / 2Terminated1
DB11659Indium1 / 2Terminated1
DB09490Indium In-111 chloride1 / 2Terminated1
DB11835Indium In-111 pentetreotide1 / 2Terminated1
DB00762Irinotecan1 / 2Recruiting1
DB06791Lanreotide1 / 2Active Not Recruiting1
DB12674Lurbinectedin1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Active Not Recruiting1
DB00958Carboplatin2Recruiting1
DB00773Etoposide2Recruiting1
DB11741Famitinib2Terminated1
DB06791Lanreotide2Completed1
DB09035Nivolumab2Recruiting1
DB00853Temozolomide2Completed1
DB13985Lutetium Lu 177 dotatate3Recruiting1